Efficacy And Safety Study Of Tanezumab Subcutaneous Administration In Osteoarthritis - A Subcutaneous/Intravenous Bridging Study
Clinical trial NCT01089725 · TERMINATED
Trial details
- NCT number
- NCT01089725
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-30
- Primary completion
- 2010-11-08
- Enrollment
- 385
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.